Poehling Capital Management, Inc. Novartis Ag Transaction History

Poehling Capital Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $384,012 - $432,269	-4,745 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$70.67 - $99.01 $10,600 - $14,851	150 Added 3.26%	4,745 $391,000
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $14,761 - $16,689	175 Added 3.96%	4,595 $435,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $33,360 - $36,761	-390 Reduced 8.11%	4,420 $384,000
Q2 2019 Aug 09, 2019	BUY	$75.4 - $92.8 $6,786 - $8,352	90 Added 1.91%	4,810 $439,000
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $2,259 - $2,584	-30 Reduced 0.63%	4,720 $454,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $27,990 - $31,167	-380 Reduced 7.41%	4,750 $408,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $104,426 - $120,790	1,560 Added 43.7%	5,130 $442,000
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $115,215 - $130,214	-1,775 Reduced 33.21%	3,570 $270,000
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $386,603 - $414,985	5,345	5,345 $449,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Poehling Capital Management, Inc. with notifications on news.